To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

United States

Research Site, Phoenix, Arizona

Research Site, Boca Raton, Florida

Research Site, Coral Springs, Florida

Research Site, Cutler Bay, Florida

Research Site, Rockville, Maryland

Research Site, Lee's Summit, Missouri

Research Site, Rochester, New York

Research Site, Cedar Park, Texas

Research Site, Humble, Texas

Research Site, Longview, Texas